Cellular origins of regenerating liver and hepatocellular carcinoma.
JHEP Rep
; 4(4): 100416, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35243280
Hepatocellular carcinoma (HCC) is the predominant primary cancer arising from the liver and is one of the major causes of cancer-related mortality worldwide. The cellular origin of HCC has been a topic of great interest due to conflicting findings regarding whether it originates in hepatocytes, biliary cells, or facultative stem cells. These cell types all undergo changes during liver injury, and there is controversy about their contribution to regenerative responses in the liver. Most HCCs emerge in the setting of chronic liver injury from viral hepatitis, fatty liver disease, alcohol, and environmental exposures. The injuries are marked by liver parenchymal changes such as hepatocyte regenerative nodules, biliary duct cellular changes, expansion of myofibroblasts that cause fibrosis and cirrhosis, and inflammatory cell infiltration, all of which may contribute to carcinogenesis. Addressing the cellular origin of HCC is the key to identifying the earliest events that trigger it. Herein, we review data on the cells of origin in regenerating liver and HCC and the implications of these findings for prevention and treatment. We also review the origins of childhood liver cancer and other rare cancers of the liver.
BEC, biliary epithelial cell; CCl4, carbon tetrachloride; CDE, choline-deficient, ethionine-supplemented; DDC, 3,5-diethoxicarbonyl-1,4-dihydrocollidine; DEN, diethylnitrosamine; EpCAM, epithelial cell adhesion molecule; FLC, fibrolamellar carcinoma; Fah, fumarylacetoacetate hydrolase; Foxl1, forkhead box L1; HB, hepatoblastoma; HBV, hepatitis B virus; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HDTVI, hydrodynamic tail vein injection; HNF, hepatocyte nuclear factor; HPC, hepatic progenitor cell; Hepatocellular carcinoma; HybHP, hybrid hepatocyte; ICC, intrahepatic cholangiocarcinoma; Krt19, cytokeratin 19; NASH, non-alcoholic steatohepatitis; OPN, osteopontin; PH, partial hepatectomy; Sox9, SRY-box 9; TAA, thioacetamide; carcinogenesis; hepatocyte; lineage tracing; progenitor cell
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
JHEP Rep
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Países Bajos